| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/02/2005 | EP1501465A2 Vectors having both isoforms of beta-hexosaminidase |
| 02/02/2005 | EP1501359A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 02/02/2005 | EP1501357A2 Use of vegf for treating bone defects |
| 02/02/2005 | EP1461620A4 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 02/02/2005 | EP1440161A4 7118, a human arginine n-methyltransferase family member and uses therefor |
| 02/02/2005 | EP1436382A4 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 02/02/2005 | EP1404334A4 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 02/02/2005 | EP1351980A4 Peptides for activation and inhibition of delta pkc |
| 02/02/2005 | EP1349589B1 A device for dispensing at least two mutually reactive components |
| 02/02/2005 | EP1221490B1 Recombinant adenoviral vectors and their utilization in the treatment of liver cirrhosis |
| 02/02/2005 | EP1175390B1 Disodium salts, monohydrates, and ethanol solvates |
| 02/02/2005 | EP1131343A4 Hydrophilic somatostatin analogs |
| 02/02/2005 | EP1100523A4 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 02/02/2005 | EP1064014B1 Medicament for preventing or treating papilloma virus-specific tumors |
| 02/02/2005 | EP0966534B1 Compositions and methods for elimination of unwanted cells |
| 02/02/2005 | EP0891420B1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0852585B1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/02/2005 | EP0832227B1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | EP0826031B1 Ataxia-telangiectasia gene and its genomic organization |
| 02/02/2005 | EP0781143B1 Method of blocking the sec receptor |
| 02/02/2005 | EP0761683B1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | EP0705110B1 Immunoglobulin infusion in xenotransplantation |
| 02/02/2005 | CN1575340A Compositions and methods for treating neurodegenerative diseases |
| 02/02/2005 | CN1575338A Bv8 nucleic acids and polypeptides with mitogenic activity |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575301A Administration of nucleic acid sequence to female animal |
| 02/02/2005 | CN1575300A Telomerase inhibitory peptides and uses thereof |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1575185A Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 02/02/2005 | CN1575184A Method and composition for treating immune complex associated disorders |
| 02/02/2005 | CN1575179A Combination product comprising melagatran and dexamethasone |
| 02/02/2005 | CN1575169A Mch antagonists for the treatment of obesity |
| 02/02/2005 | CN1572874A Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572325A Treatment of lupus nephritis with anti-CD40L compounds |
| 02/02/2005 | CN1572323A Vaccine against SARS virogene and its construction and use |
| 02/02/2005 | CN1572321A Preparation of alpha-1 protein inhibitor |
| 02/02/2005 | CN1572320A Method for erythropoietin administration using pharmacokinetic and pharmacodynamic modeling |
| 02/02/2005 | CN1572319A Guided tissue regeneration method of extracellular matrix regulated by fibromodulin |
| 02/02/2005 | CN1572318A Composition containing dipeptide of histidine and alanine for reducing uric acid |
| 02/02/2005 | CN1187451C Method of making proteins in transformed yeast cells |
| 02/02/2005 | CN1187450C Method for producing transgenic non-human mammal |
| 02/02/2005 | CN1187447C MPL ligand analogs |
| 02/02/2005 | CN1187374C Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187369C Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts |
| 02/02/2005 | CN1187361C Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof |
| 02/02/2005 | CN1187094C Polyol-IFN-beta conjugates |
| 02/02/2005 | CN1187087C Application of Batroxobin in preparing medicine for preventing and treating deficient blood-reperfusion disturbance |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/02/2005 | CN1187085C Application of erythropoietin in producing medicine for treating cerebral ischemia |
| 02/02/2005 | CN1187084C Use of alpha1 & beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/02/2005 | CN1187050C Endothelin antogonist and a renin-angiotensin system inhibitor as a combined preparation |
| 02/01/2005 | US6849719 Antibody to an IL-17 receptor like protein |
| 02/01/2005 | US6849718 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 02/01/2005 | US6849715 Agents useful for inactivation of Ras subfamily proteins |
| 02/01/2005 | US6849714 By a modification that enables the peptide to selectively conjugate to blood components, thus protecting the peptide from peptidase activity and increasing the duration of action of the therapeutic peptide for the treatment of various |
| 02/01/2005 | US6849712 Includes a C-terminal aromatic amino acid residue and an amino acid residue having a lipophilic alkyl side chain as the penultimate C-terminal residue |
| 02/01/2005 | US6849710 Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 02/01/2005 | US6849709 Aerothricin derivatives |
| 02/01/2005 | US6849708 Insulinotropic hormone and uses thereof |
| 02/01/2005 | US6849630 Cyclized amino acid derivatives |
| 02/01/2005 | US6849612 Oligonucleotide modulation of cell adhesion |
| 02/01/2005 | US6849611 Implantation of biological pacemaker that is molecularly determined |
| 02/01/2005 | US6849606 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 02/01/2005 | US6849605 A synthetic mimicking prolinamides derivatives for treating human immunodeficiency virus infection; enzyme inhibitors |
| 02/01/2005 | US6849604 A decapeptides or polypeptides, plant extracts is derived from Vernonia amygdalina leaves as antitumor agents, anticarcinogenic agents, treating breast cancer |
| 02/01/2005 | US6849603 Peptides for inhibition of apoptosis and pharmaceutical compositions containing them |
| 02/01/2005 | US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| 02/01/2005 | US6849601 A conotoxin proteins is adrenergic blocking agents, treating disorders of urinary or cardiovascular conditions, having alpha 1-adrenoceptor antagonist activity |
| 02/01/2005 | US6849600 For therapy of proliferative disorders of the skin and other tissues |
| 02/01/2005 | US6849599 Combination drug therapy |
| 02/01/2005 | US6849598 A microbiocides, bactericides, fungicides, comprising a surfactant poloxamer, optionally with EDTA, for treating bacterial infections |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 02/01/2005 | US6849596 Regulatory/unfolding peptides of ezrin |
| 02/01/2005 | US6849595 Calorically dense nutritional composition |
| 02/01/2005 | US6849593 Bifidogenic peptides |
| 02/01/2005 | US6849463 Microarray; diagnostic and detection; storage and protection of chemicals and smaller secondary devices from environmental exposure |
| 02/01/2005 | US6849452 Bringing an enriched population of resting NK cells into contact with mature or triggered dendritic cells in vitro or ex vivo, under conditions allowing activation of such resting NK cells by mature or triggered cells |
| 02/01/2005 | US6849451 Hybrid cells |
| 02/01/2005 | US6849450 Antibodies to the metalloproteinase inhibitor |
| 02/01/2005 | US6849448 Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | US6849427 Dermatophagoides pteronyssinus proteins |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849420 Isolated autophosphorylating polypeptide, possessing PI3 kinase (phosphoinositide-3 kinase) activity; use drug screening for regulators of cell motility, such as antimetastasis agents |
| 02/01/2005 | US6849417 Mammalian selenoprotein differentially expressed in tumor cells |
| 02/01/2005 | US6849415 TRAF-3 deletion isoforms and uses thereof |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 02/01/2005 | US6849399 Methods and compositions for diagnosis and treatment of iron misregulation diseases |
| 02/01/2005 | US6849279 Glycoprotein; solvent extraction; prevention pollution, ultraviolet radiation damage |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 02/01/2005 | US6849263 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 02/01/2005 | US6849262 Vascular coating composition |